PRX and ischemic stroke: Therefore, identifying the specific Prx(s) that activate TLR4 may promote the development of novel aseptic neuroinflammation models in vitro and innovative approaches with a prolonged time window for the treatment of neuroinflammation and brain injury after ischemic stroke.